2nd Quarter - Report

SOLUGEN INC for SOLUGEN INC

Firm
Client
Income
—
Expenses
$120,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Support the use of bio-based chemicals in the Department of Defense, generally. FY 2026 Defense Appropriations. FY 2026 National Defense Authorization Act.

LobbyistCovered position, as disclosed
HENRY HOLBROOK —
BRYAN J. SOUKUP —

Contacted: Defense, Dept of (DOD); SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Environment/Superfund ENV

Educate policymakers about Solugen's technology to produce bio-based chemicals, generally. Educate policymakers on the Premanufacture Notice decision for glucaric acid under (P.L. 114-182) the Frank R. Lautenberg Chemical Safety for the 21st Century Act and on the Environmental Protection Agency's chemical review process.

LobbyistCovered position, as disclosed
HENRY HOLBROOK —
BRYAN J. SOUKUP —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.